The EMINENCE consortium brings together five leading institutions, united by a common goal: the elimination of onchocerciasis in Africa. This strategic partnership harnesses expertise in clinical research, epidemiology, and public health to drive scientific innovation and accelerate efforts to combat the disease.

Each institution plays a vital role in the project, leveraging its expertise and resources to ensure the success of the clinical trial assessing the efficacy of moxidectin. Through this collaborative approach, EMINENCE plays a key role in advancing scientific knowledge and strengthening disease control strategies, contributing to a sustainable, onchocerciasis-free future.